GILD
Valuation Healthcare · Drug Manufacturers - General Data as of 2026-06-30P/E Ratio · Metrics
P/E Ratio
-
PEG Ratio
-
Dividend Yield
-
Gross Margin
79.76%
Net Margin
-134.51%
Revenue CAGR 3Y
5.75%
ROE
-357.49%
ROA
-85.05%
Buyback Yield
0.88%
Current Ratio
1.14
Magic Earn Yield
-
Altman Z-Score
-
Fair Value River
Score
Valuation 0
Profitability 20
Growth 19
Health 38
Yield 15